Title: Botulinum toxin type A in the treatment of children and adolescents with an acquired brain injury
Authors: van Rhijn, J ×
Molenaers, Guy
Ceulemans, B #
Issue Date: May-2005
Publisher: Taylor & Francis
Series Title: Brain injury vol:19 issue:5 pages:331-5
Abstract: PRIMARY OBJECTIVE: To describe clinical experience using botulinum toxin type A (BTX-A) in children with acquired brain injury. RESEARCH DESIGN: Single centre, open label, pilot study. METHODS AND PROCEDURES: Twenty-one patients were randomized to three groups according to impairment severity and treatment objectives. EXPERIMENTAL INTERVENTIONS: Group 1: Spastic quadriparesis patients with impaired consciousness treated with the primary goal of improving comfort and well-being; Group 2: Patients with upper limb spasticity treated with the primary goal of improving arm functioning; Group 3: Lower limb spasticity patients treated with the primary goal of improving leg function. OUTCOMES AND RESULTS: Baseline, 1, 3 and 5-month post-treatment assessments were carried out using joint goniometry, Modified Ashworth Scale and video-observations. All groups demonstrated initial improvements, with patients in Group 2 showing a positive effect at least 5 months post-treatment. CONCLUSIONS: With a good outlining of treatment goals, BTX-A is an effective therapy for brain injury patients.
ISSN: 0269-9052
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Orthopaedics Section (-)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science